Justice Samuel Alito temporarily paused lower court orders restricting the abortion pill in an order Friday.
The Department of Justice (DOJ) asked the Supreme Court to intervene in the case Friday morning, requesting a stay on Northern District of Texas Judge Matthew Kacsmaryk’s order suspending the Food and Drug Administration’s approval of the abortion pill. Alito granted a five-day administrative stay until Wednesday next week, allowing the court more time to make a decision on the request.
Previously, the Fifth Circuit partially blocked Judge Kacsmaryk’s order, upholding FDA approval but restricting rules implemented after 2016, which allowed the distribution of the pill via mail and extended the latest point it could be used in pregnancy to 10 weeks.
The order, which came just hours before restrictions were set to take effect, allows the Court to consider the Biden DOJ’s request for a longer stay pending appeal on the Fifth Circuit’s decision, and, if necessary, an appeal to the Supreme Court. (RELATED: DOJ To Ask Supreme Court To Intervene In Abortion Pills Case)
In the DOJ’s application filed this morning, Solicitor General Elizabeth Prelogar wrote that the lower courts’ orders would “upend the regulatory regime for mifepristone, with sweeping consequences for the pharmaceutical industry, women who need access to the drug, and FDA’s ability to implement its statutory authority.”
SCOTUS UPDATE: Justice Alito issued an administrative stay on the 5th Circuit ruling until Wednesday to allow for emergency appeal consideration.
This is a standard process for SCOTUS emergency requests. We look forward to explaining why the FDA has provided no legitimate…
— Alliance Defending Freedom (@ADFLegal) April 14, 2023
This is a breaking news story and will be updated.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact email@example.com.